Skip to main content

Year: 2023

Notice on Final Terms of the Third Tranche

UAB “Orkela”, legal entity code 304099538, registered address at Jogailos str. 4, Vilnius, the Republic of Lithuania (the Issuer). The Issuer would like to announce that pursuant to the Final Terms of the third Tranche that were adopted on 27 December 2023 (the Final Terms) in accordance with the Issuer’s Base Prospectus approved by the Bank of Lithuania on 14 November 2023, including its first supplement (the Prospectus), Offering of the Bonds under the Final Terms in the total amount of EUR 10,000,000 will be carried out in the Republic of Lithuania, Latvia and Estonia under the following main terms (other terms applicable are detailed in the Final Terms):Nominal Value of a Bond – EUR 1,000; Issue Price of a Bond – EUR 962.8118; Final Maturity Date – 19 January 2025; Interest Rate – 6% (fixed) annually; Yield – 10% annually; Subscription...

Continue reading

EVERCEL Announces Plans to Implement Liquidating Trust

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Evercel, Inc. (the “Company”) announced today that, following its initial liquidating distribution to the stockholders of the Company in April of 2023, no additional liquidating distributions would be made to the stockholders of the Company in calendar year 2023. In calendar year 2024, the Company plans to pursue the implementation of a liquidating trust for additional liquidating distributions to the stockholders of the Company in accordance with the Plan of Liquidation and Dissolution approved and adopted by the stockholders of the Company on March 30, 2023. Stockholders of the Company should work with their individual tax advisors to determine the most appropriate filing approach for the Company’s initial liquidating distribution and any additional liquidating distributions from the...

Continue reading

ARCPOINT ISSUES SHARES TO SETTLE DEBT

Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, Dec. 27, 2023 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that it has entered into an agreement dated December 24, 2023 (the “Agreement”) with an arm’s length creditor (the “Creditor”) to restructure US$1,061,718.75 in indebtedness plus accrued and unpaid interests (the “Indebtedness”) owed to the Creditor by ARCpoint Franchise Group, LLC (“AFG”), a wholly owned subsidiary of the Company. Pursuant to the terms of the Agreement, the Company agreed to, among other things, pay US$350,000 of the Indebtedness to the Creditor on January 2, 2024, and to issue 1,500,000 Class A Subordinate Voting Shares at a deemed price of CDN$0.12 per share to settle CDN$180,000 of the Indebtedness. The Company...

Continue reading

Equasens: Changes in the Equasens Group Executive Committee

Villers-lès-Nancy, 27 December 2023 – 6:00 p.m. (CET)PRESS RELEASE Changes in the Equasens Group Executive Committee Equasens Group, a leading healthcare software publisher (Euronext Paris™ – Compartment A – ISIN: FR 0012882389 – Ticker: EQS), announces a change in its Executive Committee with effect from 1 January 2024. Damien VALICON becomes the new head of the Pharmagest Division Damien VALICON, currently manager of the Medical Solutions Division, will now head up the Pharmagest Division. In this new role, he will be responsible for maintaining the commercial momentum of Pharmacie France and ASCA, supporting the growth of our European subsidiaries (PHARMAGEST Belgium, PHARMAGEST Luxembourg, PHARMAGEST Italia and the recently created PHARMAGEST Germany), as well as the development of compliance solutions...

Continue reading

Molybdenum Disulfide Market Size Worth USD 579.5 Million in 2032 | Emergen Research

Rising adoption of lubricants in various industries and increasing global utilization of Light Emitting Diode (LEDs) and lasers in electronic industries and awareness about water treatment and purification through MoS2 are key factors driving Molybdenum Disulfide (MoS2) Market revenue growth. Vancouver, Dec. 27, 2023 (GLOBE NEWSWIRE) — The global Molybdenum Disulfide (moS2) market size was USD 442.4 Million in 2022 and is expected to register a rapid revenue CAGR of 2.8% during the forecast period. Key drivers include the increasing adoption of lubricants in diverse industries, growing utilization of Light Emitting Diodes (LEDs) and lasers in electronic applications, and rising awareness of MoS2 applications in water treatment. MoS2, an inorganic compound composed of one molybdenum atom and two sulfur atoms, comes in two essential...

Continue reading

Nxu Executes Strategic Partnership and Investment in Lynx Motors

Nxu finalizes transaction with Lynx MESA, Ariz., Dec. 27, 2023 (GLOBE NEWSWIRE) — Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company creating innovative EV charging and energy storage solutions for the infrastructure we need to power our electrified future, has executed definitive documents to finalize its strategic investment in Lynx Motors. This transaction both memorializes Nxu’s commitment to utilizing strategic partnerships to accelerate its mission to develop superior highway electrification and demonstrates continued execution of Nxu’s Nasdaq compliance plan. The financial impact of the transaction results in an increase in Nxu’s shareholder equity and helps to ensure that Nxu can achieve and maintain Nasdaq’s continued listing standards by and beyond Nasdaq’s extension deadline of April 7, 2024. “We’re...

Continue reading

VÍS: Hluthafafundur Vátryggingafélags Íslands 17. janúar 2024

Hluthafafundur Vátryggingafélags Íslands hf. Stjórn Vátryggingafélags Íslands hf. boðar til hluthafafundar í félaginu sem haldinn verður miðvikudaginn 17. janúar 2024 kl. 16:00 í höfuðstöðvum félagsins að Ármúla 3, Reykjavík. Fundarboð með upplýsingum um dagskrá fundarins ásamt tillögum stjórnar, má finna í meðfylgjandi viðhengjum. Nánari upplýsingar veitir Erla Tryggvadóttir, samskiptastjóri VÍS, í síma 660-5260 eða með netfanginu fjarfestatengsl@vis.isAttachmentsHluthafafundarboð_17-01-2024Ályktunartillaga stjórnar Vátryggingafélags Íslands hf

Continue reading

Fleet Management Market Size Worth USD 59.29 Billion in 2032 | Emergen Research

Increasing concerns regarding fleet safety is one of the major factors driving fleet management market revenue growth Vancouver, Dec. 27, 2023 (GLOBE NEWSWIRE) — The global fleet management market size was USD 23.20 Billion in 2022 and is expected to register a steady revenue CAGR of 9.9% during the forecast period, according to latest analysis by Emergen Research. Increasing concerns regarding fleet safety is a key factor driving market revenue growth. Fleet management tracks and manages the location and condition of fleet vehicles and other fleet assets. The fleet management system monitors and records driving behavior, such as speeding, forceful braking and acceleration, idling, and others, and automatically generates customizable reports based on data collected to determine where and when drivers engage in unsafe driving behaviors. In...

Continue reading

Enento Group Plc: SHARE REPURCHASE 27.12.2023

Enento Group Plc ANNOUNCEMENT 27.12.2023          Enento Group Plc: SHARE REPURCHASE 27.12.2023       In the Helsinki Stock Exchange         Trade date 27.12.2023  Bourse trade Buy  Share ENENTO  Amount 1,365 SharesAverage price/ share 18.9495 EURTotal cost 25,866.07 EUR          Enento Group Plc now holds a total of 4 676 sharesincluding the shares repurchased on 27.12.2023          On behalf of Enento Group Plc         Nordea Bank Oyj              Janne Sarvikivi Sami Huttunen       For further information:    Arto Paukku    Investor Relations Officer    tel. +358 50 469 5380         www.enento.com    AttachmentEnento 27.12 trades

Continue reading

First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced

BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced it has entered into agreements with certain holders of its existing warrants exercisable for 881,337 shares of its common stock, in the aggregate, to exercise their warrants at a reduced exercise price of $5.50 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $4.8 million, before deducting financial advisory fees. The reduction in the exercise price of the existing warrants and the issuance of the new warrants was structured...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.